Page 1

HENRY SCHEIN SOLUTIONS FOR HEALTH CARE PROFESSIONALS Henry Schein Reports Record First - Quarter 2021 Financial Results from Continuing Operations May 4 , 2021 • Total net sales of $ 2.9 billion up 20.4 % versus prior year • GAAP diluted EPS from continuing operations of $ 1.16 versus prior - year GAAP diluted EPS from continuing operations of $ 0.91 • Non - GAAP diluted EPS from continuing operations of $ 1.24 versus prior - year non - GAAP diluted EPS from continuing operations of $ 0.94 • Reflecting strong first - quarter results , the Company raises guidance for 2021 non - GAAP diluted EPS from continuing operations to be at or above $ 3.70 MELVILLE , N.Y .-- ( BUSINESS WIRE ) -- May 4 , 2021-- Henry Schein , Inc. ( Nasdaq : HSIC ) , the world's largest provider of health care solutions to office - based dental and medical practitioners , today reported record first - quarter financial results from continuing operations . Results from continuing operations exclude contributions from Henry Schein's former Animal Health business , which was spun off in February 2019 to form a new publicly traded company , Covetrus ( Nasdaq : CVET ) . Total net sales for the quarter ended March 27 , 2021 , were $ 2.9 billion , up 20.4 % compared with the first quarter of 2020. The 20.4 % increase included 14.9 % internal growth in local currencies , 3.3 % growth from acquisitions , and 2.2 % growth related to foreign currency exchange . ( See Exhibit A for details of sales growth ) . GAAP net income attributable to Henry Schein , Inc. from continuing operations for the first quarter of 2021 was $ 166.0 million , or $ 1.16 per diluted share , compared with prior - year GAAP net income from continuing operations of $ 130.5 million , or $ 0.91 per diluted share . Non - GAAP net income from continuing operations for the first quarter of 2021 was $ 177.7 million , or $ 1.24 per diluted share , compared with prior - year non - GAAP net income from continuing operations of $ 134.1 million , or $ 0.94 per diluted share . Exhibit B provides a reconciliation of GAAP net income and diluted EPS from continuing operations to non - GAAP net income and diluted EPS from continuing operations . " We are pleased with exceptional first - quarter global financial performance versus the comparable prior - year period , and also compared to the first quarter of 2019 , which is the result of planning and excellent execution across all of our businesses . We also delivered a very strong operating margin for the quarter . While end markets in most geographies still face challenges due to the ongoing pandemic , the overall market recovery and our improving financial results have continued . Our positive momentum reflects the adaptiveness of our business model as well as the commitment of Team Schein Members to our customers and our communities , " said Stanley M. Bergman , Chairman of the Board and Chief Executive Officer of Henry Schein . " Throughout these unprecedented times , Henry Schein has remained focused on the safety of our team and on responding to our customers ' needs , as well as on driving innovation , gaining market share , enhancing our margin profile , and optimizing our cost structure . We believe all of this positions us well to continue to drive earnings growth and create value over the long - term . " Global Dental sales for the first quarter of 2021 of $ 1.8 billion increased 21.3 % versus the prior - year period . In local currencies , internally generated sales increased 13.7 % with 4.2 % growth from acquisitions and 3.4 % growth related to foreign currency exchange . The 13.7 % internal growth in local currencies included an increase of 10.9 % in North America and an increase of 17.9 % internationally . Global Dental consumable merchandise internal sales increased by 13.2 % in local currencies . Excluding sales of personal protective equipment ( PPE ) and COVID - 19 related products , growth was 10.9 % . In North America , dental consumable merchandise internal sales in local currencies increased 9.3 % , or 6.9 % excluding sales of PPE and COVID - 19 related products , and dental equipment internal sales in local currencies increased 17.4 % . Internationally , dental consumable merchandise internal sales in local currencies increased 19.2 % , or 16.7 % excluding sales of PPE and COVID - 19 related products , and dental equipment internal sales in local currencies increased 12.9 % . " For the first quarter , our dental sales in both North America and international markets were strong , including significant growth in North America dental equipment sales versus the fourth quarter of 2020 , " noted Mr. Bergman . " Global Dental Specialty sales were also strong with year - over - year internal growth of 18.3 % in local currencies . We remain optimistic about the stability and health of the global dental markets we serve , despite rising COVID - 19 cases in certain geographies , as patient traffic and practice spending have steadily improved since the first few months of the pandemic . " Global Medical sales for the first quarter of 2021 of $ 993.0 million increased 24.0 % versus the comparable period last year , consisting of 22.1 % internal growth in local currencies , 1.6 % growth from acquisitions and 0.3 % growth related to foreign currency exchange . Excluding sales of PPE and COVID - 19 related products , internal sales in local currencies decreased 6.8 % , in part resulting from an extremely mild influenza season that impacted diagnostic and consumable merchandise sales , as well as from lower pharmaceutical sales related to fewer patient office visits due to COVID - 19 . " We are pleased to report strong double - digit global Medical sales growth during the first quarter . We expect the physician , ambulatory surgery center , alternate care and home health markets to improve over time as infection levels abate and patient volumes normalize . That said , we expect COVID - 19 test sales to decline , primarily as a result of unit price erosion , " remarked Mr. Bergman . " While sales of PPE products have begun to moderate from recent quarterly growth rates in both our Dental and Medical businesses , we expect PPE sales will remain at elevated levels as dentists and physicians implement new standard - of - care best practices , " said Mr. Bergman . Global Technology and Value - Added Services sales of $ 143.0 million increased 8.4 % versus the prior - year quarter and included 3.6 % internal sales growth in local currencies , 3.4 % growth from acquisitions and 1.4 % growth related to foreign currency exchange . " Global Technology and Value - Added Services sales have steadily improved over the last several quarters , with Henry Schein One internal sales in local currencies increasing by 2.6 % in the first quarter , representing continued sequential - quarter growth . In addition , financial services internal sales in local currencies increased by 22.5 % , in part driven by higher sales of dental equipment , " noted Mr. Bergman .